Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Human Immunology|June 21, 2016
Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cellsArvind Chhabra, Bijay MukherjiJournal of Immunology (Baltimore, Md. : 1950)|August 13, 2013
Death receptor-independent activation-induced cell death in human melanoma antigen-specific MHC class I-restricted TCR-engineered CD4 T cellsArvind Chhabra, Bijay MukherjiCancer Immunology, Immunotherapy : CII|May 13, 2017
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapiesUpendra P Hegde, Bijay MukherjiExpert Opinion on Therapeutic Targets|December 10, 2016
Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53Arvind Chhabra, Bijay Mukherji, Deepika BatraClinical Immunology (Orlando, Fla.)|February 6, 2008
Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35Arvind Chhabra, Nitya G Chakraborty, Bijay MukherjiCancer Immunology, Immunotherapy : CII|May 4, 2005
Regulatory T cells and tumor immunitySubhasis Chattopadhyay, Nitya G Chakraborty, Bijay MukherjiPathobiology : Journal of Immunopathology, Molecular and Cellular Biology|February 23, 2007
Macrophages as stimulators of MART-1 27-35 epitope-specific human cytolytic T lymphocytes in vitroShikhar Mehrotra, Nisar Zaidi, Nitya G Chakraborty, et al.Journal of Family Medicine and Primary Care|July 26, 2016
Medical Education: The Hot SeatRanabir Pal, Raman Kumar, Shrayan Pal, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 12, 2011
Metastatic melanoma in the older patient: immunologic insights and treatment outcomesUpendra P Hegde, Nitya Chakraborty, Bijay Mukherji, et al.Pageof 3